Product Information
CLONAZEPAM 0.5 MG TABLET is a generic product labeled by Advagen Pharma Ltd., priced at $0.0199 per EA under NDC 72888015205. Its NADAC has been published 161 times since May 31, 2023.
Strength
.5 mg/1
Manufacturer
Advagen Pharma Ltd.NDC
72888015205
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CLONAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA075468On Market Since
4/14/2022
Pharmacological Classes
Price Statistics
The NADAC for CLONAZEPAM 0.5 MG TABLET has been published 161 times since May 31, 2023, and over the history we have for it it has declined 30.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0199 per EA |
|---|---|
| All-time high | $0.0302 (Jul 12, 2023) |
| All-time low | $0.0174 (Nov 20, 2024) |
| 52-week high | $0.0224 |
| 52-week low | $0.0198 |
| Median price | $0.0221 |
| Average price | $0.0232 |
| Largest weekly change | -34.1% (Nov 20, 2024) |
| Weeks tracked | 161 |
| Tracking since | May 31, 2023 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CLONAZEPAM 0.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CLONAZEPAM 0.5 MG TABLET, manufactured by Advagen Pharma Ltd., is $0.0199 per EA (NDC 72888015205), effective Jun 24, 2026.
How has the price of CLONAZEPAM 0.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for CLONAZEPAM 0.5 MG TABLET has declined 30.5%. It has been tracked across 161 weekly CMS publications since May 31, 2023.
What are the highest and lowest recorded NADAC prices for CLONAZEPAM 0.5 MG TABLET?
Since May 31, 2023, the NADAC for CLONAZEPAM 0.5 MG TABLET has ranged from a low of $0.0174 (Nov 20, 2024) to a high of $0.0302 (Jul 12, 2023), with a median of $0.0221 per EA.
Are there cheaper alternatives to CLONAZEPAM 0.5 MG TABLET?
6 NADAC-published products share the same active ingredient, strength, and dosage form as CLONAZEPAM 0.5 MG TABLET, but none are currently priced below it.
Who manufactures CLONAZEPAM 0.5 MG TABLET?
CLONAZEPAM 0.5 MG TABLET (NDC 72888015205) is labeled by Advagen Pharma Ltd., and CMS classifies it as a generic product.
Related Drugs
Same classification